The DOI matches its Crossref record; 353 of the 353 references it cites were found in a registry or an index.
Monoamine transporters and psychostimulant addiction
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dopamine agonists for cocaine dependence
Soares, B. G., Reisser, A. A. L., Farrell, M., & de Lima, M. S. (2003) · doi:10.1002/14651858.cd003352 · Cited by 83
RetractedA review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Kalivas, P. W., & Stewart, J. (1991) · Brain Research Reviews · doi:10.1016/0165-0173(91)90007-u · Cited by 2,019
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., & Gouaux, E. (2005) · Nature · doi:10.1038/nature03978 · Cited by 1,661
The psychology and neurobiology of addiction: an incentive–sensitization view
Robinson, T. E., & Berridge, K. C. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.19.x · Cited by 1,507
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Incentive-sensitization and addiction
Robinson, T. E., & Berridge, K. C. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.9611038.x · Cited by 1,435
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Le Moal, M., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,351
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,346
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Neurotransmitter Transporters: Recent Progress
Amara, S. G., & Kuhar, M. J. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.000445 · Cited by 1,082
Reversal of Phencyclidine Effects by a Group II Metabotropic Glutamate Receptor Agonist in Rats
Moghaddam, B., & Adams, B. W. (1998) · Science · doi:10.1126/science.281.5381.1349 · Cited by 1,006
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001) · Synapse · doi:10.1002/1098-2396(20010101)39:1<32::aid-syn5>3.0.co;2-3 · Cited by 938
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli
Garavan, H., Pankiewicz, J., Bloom, A., Cho, J.-K., Sperry, L., Ross, T. J., Salmeron, B. J., Risinger, R., Kelley, D., & Stein, E. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1789 · Cited by 931
Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
McFarland, K., Lapish, C. C., & Kalivas, P. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03531.2003 · Cited by 885
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
Shank, R. P., Gardocki, J. F., Streeter, A. J., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02163.x · Cited by 810
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Dopaminergic Role in Stimulant-Induced Wakefulness
Wisor, J. P., Nishino, S., Sora, I., Uhl, G. H., Mignot, E., & Edgar, D. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 769
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 739
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Relationship between subjective effects of cocaine and dopamine transporter occupancy
Volkow, N. D., Wang, G.-J., Fischman, M. W., Foltin, R. W., Fowler, J. S., Abumrad, N. N., Vitkun, S., Logan, J., Gatley, S. J., Pappas, N., et al. (1997) · Nature · doi:10.1038/386827a0 · Cited by 653
Thomas, M. J., Beurrier, C., Bonci, A., & Malenka, R. C. (2001) · Nature Neuroscience · doi:10.1038/nn757 · Cited by 629
Pierce, R., Bell, K., Duffy, P., & Kalivas, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-04-01550.1996 · Cited by 623
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.019 · Cited by 616
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594 · cited 2×
“The first disease-associated SLC6 protein variant, A457P, has no transport activity, decreased cell surface expression, and is associated with orthostatic intolerance [97,98].”
BackgroundA cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter
Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 594
The dopamine transporter: immunochemical characterization and localization in brain
Ciliax, B., Heilman, C., Demchyshyn, L., Pristupa, Z., Ince, E., Hersch, S., Niznik, H., & Levey, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01714.1995 · Cited by 589
The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate
Baker, D. A., Xi, Z.-X., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584
Molecular characterization of the dopamine transporter
Giros, B., & Caron, M. G. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90029-j · Cited by 562
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 545
Kalivas, P., & Duffy, P. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-01-00266.1993 · Cited by 509
Monoamine transporters and psychostimulant drugs
Rothman, R. B., & Baumann, M. H. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.054 · Cited by 502
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493
Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
Erickson, J. D., Eiden, L. E., & Hoffman, B. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10993 · Cited by 487
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Tzschentke, T. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00033-2 · Cited by 481
PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys
Nader, M. A., Morgan, D., Gage, H. D., Nader, S. H., Calhoun, T. L., Buchheimer, N., Ehrenkaufer, R., & Mach, R. H. (2006) · Nature Neuroscience · doi:10.1038/nn1737 · Cited by 481
Erickson, J. D., Schafer, M. K., Bonner, T. I., Eiden, L. E., & Weihe, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.5166 · Cited by 479
Giros, B., el Mestikawy, S., Godinot, N., Zheng, K., Han, H., Yang-Feng, T., & Caron, M. G. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08925-4 · Cited by 477
From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters
Rudnick, G., & Clark, J. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90109-s · Cited by 469
Changes in brain glucose metabolism in cocaine dependence and withdrawal
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.5.621 · Cited by 455
Sonders, M. S., Zhu, S.-J., Zahniser, N. R., Kavanaugh, M. P., & Amara, S. G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-03-00960.1997 · Cited by 444
Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 414
Molecular Neurobiology of Addiction
Nestler, E. J. (2001) · The American Journal on Addictions · doi:10.1080/105504901750532094 · Cited by 412
Carboni, E., Tanda, G. L., Frau, R., & Chiara, G. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04599.x · Cited by 411
A Medical Treatment for Diacetylmorphine (Heroin) Addiction
Dole, V. P., & Nyswander, M. (1966) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-196604000-00028 · Cited by 404
Kalivas, P., & Duffy, P. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-01-00276.1993 · Cited by 403
Electrophysiological Characterization of GABAergic Neurons in the Ventral Tegmental Area
Steffensen, S. C., Svingos, A. L., Pickel, V. M., & Henriksen, S. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-19-08003.1998 · Cited by 394
Bergman, J., Madras, B. K., Johnson, S. E., & Spealman, R. D. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20689-9 · Cited by 394
Ramamoorthy, S., & Blakely, R. D. (1999) · Science · doi:10.1126/science.285.5428.763 · Cited by 392
Mello, N. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00274-h · Cited by 392
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391 · cited 2×
“[347] Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O’Brien CP.”
BackgroundQian, Y., Galli, A., Ramamoorthy, S., Risso, S., DeFelice, L. J., & Blakely, R. D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00045.1997 · Cited by 381
Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter
Melikian, H. E., & Buckley, K. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07699.1999 · Cited by 374
Hervé, D., Pickel, V. M., Joh, T. H., & Beaudet, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91588-5 · Cited by 372
SESACK, S. R., CARR, D. B., OMELCHENKO, N., & PINTO, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.066 · Cited by 367
Kalivas, P. W., & Alesdatter, J. E. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39530-3 · Cited by 367
Kita, H., & Kitai, S. T. (1988) · Brain Research · doi:10.1016/0006-8993(88)91138-9 · Cited by 364
Woolverton, W. L., & Johnson, K. M. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90063-c · Cited by 355
Regulated Trafficking of the Human Dopamine Transporter
Daniels, G. M., & Amara, S. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35794 · Cited by 352
Martinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D.-R., Broft, A., Huang, Y., Cooper, T. B., Fischman, M. W., Kleber, H. D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.622 · Cited by 351
Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine
Horger, B. A., Giles, M. K., & Schenk, S. (1992) · Psychopharmacology · doi:10.1007/bf02245147 · Cited by 344
Differential expression of two vesicular monoamine transporters
Peter, D., Liu, Y., Sternini, C., de Giorgio, R., Brecha, N., & Edwards, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-09-06179.1995 · Cited by 333
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.
Varnäs, K., Halldin, C., & Hall, H. (2004) · Human Brain Mapping · doi:10.1002/hbm.20035 · Cited by 332
The Principles of Addiction Medicine
(2007) · Addiction and the Medical Complications of Drug Abuse · doi:10.1201/9781420054446-5 · Cited by 332
Vesicular neurotransmitter transporters: from bacteria to humans.
Schuldiner, S., Shirvan, A., & Linial, M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.2.369 · Cited by 326
Johnson, R. G. (1988) · Physiological Reviews · doi:10.1152/physrev.1988.68.1.232 · Cited by 323
Modafinil Binds to the Dopamine Uptake Carrier Site with Low Affinity
Mignot, E., Nishino, S., Guilleminault, C., & Dement, W. C. (1994) · Sleep · doi:10.1093/sleep/17.5.436 · Cited by 318
Phosphorylation and Regulation of Antidepressant-sensitive Serotonin Transporters
Ramamoorthy, S., Giovanetti, E., Qian, Y., & Blakely, R. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2458 · Cited by 315
A pilot trial of topiramate for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H., Lynch, K. G., Dackis, C., Sparkman, T., Weigley, C., & O’Brien, C. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.03.008 · Cited by 313
Neurotransmitter transporters: molecular function of important drug targets
GETHER, U., ANDERSEN, P., LARSSON, O., & SCHOUSBOE, A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.003 · Cited by 309
Behavioral and neurochemical effects of acute and daily cocaine administration in rats.
Kalivas, P. W., Duffy, P., DuMars, L. A., & Skinner, C. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22646-5 · Cited by 302
α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates
Drouin, C., Darracq, L., Trovero, F., Blanc, G., Glowinski, J., Cotecchia, S., & Tassin, J.-P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02873.2002 · Cited by 296
THE ROLE OF VESICULAR TRANSPORT PROTEINS IN SYNAPTIC TRANSMISSION AND NEURAL DEGENERATION
Liu, Y., & Edwards, R. H. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.125 · Cited by 296
Grenhoff, J., Nisell, M., Ferr�, S., Aston-Jones, G., & Svensson, T. H. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244934 · Cited by 292
Vaughan, R. A., Huff, R. A., Uhl, G. R., & Kuhar, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15541 · Cited by 290
Synaptic regulation of mesocorticolimbic dopamine neurons
White, F. J. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.002201 · Cited by 289
Psychomotor stimulants and neuronal plasticity
Wolf, M. E., Sun, X., Mangiavacchi, S., & Chao, S. Z. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.006 · Cited by 288
Vezina, P. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02411.1996 · Cited by 283
Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?
Carlezon, W. A., & Nestler, E. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02289-0 · Cited by 281
Principles of Addiction Medicine
Matthews, A. (2004) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.291.1.112-b · Cited by 280
Hoffman, B. J., Hansson, S. R., Mezey, É., & Palkovits, M. (1998) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0168 · Cited by 279
Oligomerization and Trafficking of the Human Dopamine Transporter
Torres, G. E., Carneiro, A., Seamans, K., Fiorentini, C., Sweeney, A., Yao, W.-D., & Caron, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m201926200 · Cited by 278
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype
Ozaki, N., Goldman, D., Kaye, W. H., Plotnicov, K., Greenberg, B. D., Lappalainen, J., Rudnick, G., & Murphy, D. L. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001365 · Cited by 275
Alpha-2 Adrenergic Receptor Agonists Block Stress-Induced Reinstatement of Cocaine Seeking
Erb, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00158-x · Cited by 270
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00672-6 · Cited by 270
Kuczenski, R., & Segal, D. S. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38829-9 · Cited by 267
Wolf, M. E., Dahlin, S. L., Hu, X.-T., Xue, C.-J., & White, K. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00248-h · Cited by 261
Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence
Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.018 · Cited by 257
Neurotransmitter transporters : structure, function, and regulation
Reith, M. E. A. (2002) · Humana Press eBooks · Cited by 255
Fluoxetine reduces intravenous cocaine self-administration in rats
Carroll, M. E., Lac, S. T., Asencio, M., & Kragh, R. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90232-7 · Cited by 254
Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats
Eberle-Wang, K., Mikeladze, Z. A., Uryu, K., & Chesselet, M. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970728)384:2<233::aid-cne5>3.0.co;2-2 · Cited by 251
Di Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00047-7 · Cited by 251
Schubiner, H., Downey, K. K., Arfken, C. L., Johanson, C.-E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., & Pihlgren, E. (2002) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.10.3.286 · Cited by 249
Madras, B. K., Fahey, M. A., Bergman, J., Canfield, D. R., & Spealman, R. D. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20684-x · Cited by 244
Wolf, M. E., & Jeziorski, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90913-8 · Cited by 243
GABAB receptor agonists for the treatment of drug addiction: a review of recent findings
Cousins, M. S., Roberts, D. C. S., & Wit, H. D. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00163-6 · Cited by 240
Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
Blandina, P., Goldfarb, J., Craddock-Royal, B., & Green, J. P. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21081-3 · Cited by 240
Letchworth, S. R., Nader, M. A., Smith, H. R., Friedman, D. P., & Porrino, L. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02799.2001 · Cited by 239
Molecular biology of the dopamine receptors
Civelli, O., Bunzow, J. R., Grandy, D. K., Zhou, Q.-Y., & Van Tol, H. H. M. (1991) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(91)90001-x · Cited by 239
Bauman, A. L., Apparsundaram, S., Ramamoorthy, S., Wadzinski, B. E., Vaughan, R. A., & Blakely, R. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07571.2000 · Cited by 235
Oligomerization of serotonin transporter and its functional consequences
Kilic, F., & Rudnick, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3106 · Cited by 235
Role of 5-HT2C receptors in the control of central dopamine function
Di Matteo, V., De Blasi, A., Di Giulio, C., & Esposito, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01688-6 · Cited by 234
Swanson, C. J., Baker, D. A., Carson, D., Worley, P. F., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-09043.2001 · Cited by 230
Sonders, M. S., & Amara, S. G. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80111-5 · Cited by 230
Disulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 228
Parsons, L. H., Koob, G. F., & Weiss, F. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10596-x · Cited by 218
Tzschentke, T. M., & Schmidt, W. J. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i2.20 · Cited by 218
Hastrup, H., Karlin, A., & Javitch, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181344298 · Cited by 217
Shoptaw, S., Yang, X., Rotheram-Fuller, E. J., Hsieh, Y.-C. M., Kintaudi, P. C., Charuvastra, V. C., & Ling, W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1207 · Cited by 215
Prisco, S., Pagannone, S., & Esposito, E. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22843-9 · Cited by 214
Fleckenstein, A. E., Gibb, J. W., & Hanson, G. R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00639-7 · Cited by 213
Group II Metabotropic Glutamate Receptors Modulate Extracellular Glutamate in the Nucleus Accumbens
Xi, Z.-X., Baker, D. A., Shen, H., Carson, D. S., & Kalivas, P. W. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.162 · Cited by 212
Wee, S., Anderson, K. G., Baumann, M. H., Rothman, R. B., Blough, B. E., & Woolverton, W. L. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080101 · Cited by 211
Dewey, S., Smith, G., Logan, J., Brodie, J., Yu, D., Ferrieri, R., King, P., MacGregor, R., Martin, T., & Wolf, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03773.1992 · Cited by 211
Gresch, P. J., Sved, A. F., Zigmond, M. J., & Finlay, J. M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010111.x · Cited by 208
Nader, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00427-4 · Cited by 206
Intravenous self-administration of dopamine receptor agonists by rhesus monkeys.
Woolverton, W. L., Goldberg, L. I., & Ginos, J. Z. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21719-0 · Cited by 204
Anderson, S. M., & Pierce, R. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.12.004 · Cited by 204
Stevens Negus, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300096 · Cited by 203
Bolan, E. A., Kivell, B., Jaligam, V., Oz, M., Jayanthi, L. D., Han, Y., Sen, N., Urizar, E., Gomes, I., Devi, L. A., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.027763 · Cited by 202
Ventura, R., Cabib, S., Alcaro, A., Orsini, C., & Puglisi-Allegra, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01879.2003 · Cited by 198
A novel strategy for the treatment of cocaine addiction
Dewey, S. L., Morgan, A. E., Ashby, C. R., Horan, B., Kushner, S. A., Logan, J., Volkow, N. D., Fowler, J. S., Gardner, E. L., & Brodie, J. D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2<119::aid-syn1>3.0.co;2-f · Cited by 195
Replacement Medication for Cocaine Dependence: Methylphenidate
Grabowski, J., Roache, J. D., Schmitz, J. M., Rhoades, H., Creson, D., & Korszun, A. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199712000-00008 · Cited by 191
Berridge, C. W., Stratford, T. L., Foote, S. L., & Kelley, A. E. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199711)27:3<230::aid-syn8>3.0.co;2-e · Cited by 190
The Role of N-Glycosylation in Function and Surface Trafficking of the Human Dopamine Transporter
Li, L.-B., Chen, N., Ramamoorthy, S., Chi, L., Cui, X.-N., Wang, L. C., & Reith, M. E. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311972200 · Cited by 189
Cocaine inhibits GABA release in the VTA through endogenous 5-HT
Cameron, D., & Williams, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06763.1994 · Cited by 188
Castner, S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00050-5 · Cited by 187
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study
Dackis, C. A., Lynch, K. G., Yu, E., Samaha, F. F., Kampman, K. M., Cornish, J. W., Rowan, A., Poole, S., White, L., & O'Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00335-6 · Cited by 186
Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release
Reid, M. S., & Berger, S. P. (1996) · NeuroReport · doi:10.1097/00001756-199605170-00022 · Cited by 185
Di Matteo, V., Di Giovanni, G., Di Mascio, M., & Esposito, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02246-0 · Cited by 184
Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.
Rose, J. E., Behm, F. M., & Westman, E. C. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.3.331 · Cited by 183
Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula
Ellison, G. (1994) · Brain Research Reviews · doi:10.1016/0165-0173(94)90012-4 · Cited by 182
Woolverton, W. L. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90553-8 · Cited by 181
Stewart, J., & Vezina, P. (1989) · Brain Research · doi:10.1016/0006-8993(89)90236-9 · Cited by 181
Modulation of Group II Metabotropic Glutamate Receptor Signaling by Chronic Cocaine
Xi, Z.-X., Ramamoorthy, S., Baker, D. A., Shen, H., Samuvel, D. J., & Kalivas, P. W. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039735 · Cited by 181
Zhu, S.-J., Kavanaugh, M. P., Sonders, M. S., Amara, S. G., & Zahniser, N. R. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36962-9 · Cited by 181
Weiss, S. R. B., Post, R. M., Pert, A., Woodward, R., & Murman, D. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(89)80001-2 · Cited by 180
Strakowski, S. M., Sax, K. W., Setters, M. J., & Keck, P. E. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00497-1 · Cited by 179
Pharmacological treatment of cocaine dependence: a systematic review
Lima, M. S. D., Soares, B. G. D. O., Reisser, A. A. P., & Farrell, M. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00209.x · Cited by 178
Pristupa, Z. B., McConkey, F., Liu, F., Man, H., Lee, F. J. S., Wang, Y. T., & Niznik, H. B. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199809)30:1<79::aid-syn10>3.0.co;2-k · Cited by 176
Ritz, M. C., & Kuhar, M. J. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24116-7 · Cited by 176
Staley, J. K., Hearn, W. L., Ruttenber, A. J., Wetli, C. V., & Mash, D. C. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24057-5 · Cited by 175
Serotonin1BReceptor Stimulation Enhances Cocaine Reinforcement
Parsons, L. H., Weiss, F., & Koob, G. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10078.1998 · Cited by 174
Martin-Söelch, C., Leenders, K. L., Chevalley, A. ‐., Missimer, J. H., Künig, G., Magyar‐Lehmann, S., Mino, A., & Schultz, W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00089-3 · Cited by 173
Melikian, H. E., Ramamoorthy, S., Tate, C. G., & Blakely, R. D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09218-1 · Cited by 171
Responses of primate locus coeruleus neurons to simple and complex sensory stimuli
Grant, S. J., Aston-Jones, G., & Redmond, D. E. (1988) · Brain Research Bulletin · doi:10.1016/0361-9230(88)90152-9 · Cited by 170
Dopamine Transporters Are Phosphorylated on N-terminal Serines in Rat Striatum
Foster, J. D., Pananusorn, B., & Vaughan, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200294200 · Cited by 168
Cases, O., Lebrand, C., Giros, B., Vitalis, T., Maeyer, E. D., Caron, M. G., Price, D. J., Gaspar, P., & Seif, I. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-17-06914.1998 · Cited by 167
Battaglia, G., Monn, J. A., & Schoepp, D. D. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00442-4 · Cited by 163
A Human Serotonin Transporter Mutation Causes Constitutive Activation of Transport Activity
Kilic, F., Murphy, D. L., & Rudnick, G. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.440 · Cited by 162
Pharmacotherapy for Cocaine-Abusing Methadone-Maintained Patients Using Amantadine or Desipramine
Kosten, T. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110058009 · Cited by 162
Critical Role for Ventral Tegmental Glutamate in Preference for a Cocaine-Conditioned Environment
Harris, G. C., & Aston-Jones, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300011 · Cited by 162
Jayanthi, L. D., Samuvel, D. J., & Ramamoorthy, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311172200 · Cited by 161
Medications development: Successes and challenges
Vocci, F., & Ling, W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.010 · Cited by 160
Strakowski, S. M., & Sax, K. W. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00454-x · Cited by 160
Apparsundaram, S., Schroeter, S., Giovanetti, E., & Blakely, R. D. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37852-8 · Cited by 160
Lee, B., Tiefenbacher, S., Platt, D. M., & Spealman, R. D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300391 · Cited by 160
Regulation of the functional activity of the human dopamine transporter by protein kinase C
Zhang, L., Coffey, L. L., & Reith, M. E. A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00898-2 · Cited by 159
Neurochemical changes in cocaine withdrawal
Kuhar, M. J., & Pilotte, N. S. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10024-9 · Cited by 159
Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine Transporter
Erickson, J. D., & Eiden, L. E. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07476.x · Cited by 159
Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain
Kleven, M. S., Perry, B. D., Woolvertom, W. L., & Seiden, L. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)91768-c · Cited by 158
Neurotransmitter transporters: three distinct gene families
Amara, S., & Arriza, J. L. (1993) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(93)90126-j · Cited by 158
Campbell, U. C., Lac, S. T., & Carroll, M. E. (1999) · Psychopharmacology · doi:10.1007/s002130050937 · Cited by 157
Apparsundaram, S., Galli, A., DeFelice, L. J., Hartzell, H. C., & Blakely, R. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37851-6 · Cited by 157
Dopamine D1 and D2 mediation of the discriminative stimulus properties ofd-amphetamine and cocaine
Callahan, P. M., Appel, J. B., & Cunningham, K. A. (1991) · Psychopharmacology · doi:10.1007/bf02244073 · Cited by 157
Malison, R. T., Best, S. E., van Dyck, C. H., McCance, E. F., Wallace, E. A., Laruelle, M. A., Baldwin, R. M., Seibyl, J. P., Price, L. H., Kosten, T. R., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.832 · Cited by 156
Grabowski, J. G., Rhoades, H. M., Elk, R., Schmitz, J. M., Davis, C., Creson, D., & Kirby, K. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00004 · Cited by 155
Spealman, R. D., Madras, B. K., & Bergman, J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20686-3 · Cited by 150
The dopamine receptor family: molecular biology and pharmacology
Schwartz, J.-C., Bruno Giros, A., Martres, M., & Sokoloff, P. (1992) · Seminars in Neuroscience · doi:10.1016/1044-5765(92)90008-p · Cited by 148
Brebner, K., Phelan, R., & Roberts, D. C. S. (2000) · Psychopharmacology · doi:10.1007/s002130050056 · Cited by 147
Mateo, Y., Läck, C. M., Morgan, D., Roberts, D. C. S., & Jones, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300687 · Cited by 146
The Regulation of Dopamine Transmission by Metabotropic Glutamate Receptors
Hu, G., Duffy, P., Swanson, C. J., Ghasemzadeh, M. B., & Kalivas, P. W. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38151-0 · Cited by 140
The GABAB agonist baclofen modifies cocaine self-administration in rats.
Shoaib, M., SWANNER, L. S., Ce, B., Goldberg, & Schindler, C. W. (1998) · PubMed · Cited by 140
Desipramine Treatment of Cocaine Dependence in Methadone-Maintained Patients
Arndt, I. O. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110052008 · Cited by 139
Permeation Properties of Neurotransmitter Transporters
Lester, H. A., Mager, S., Quick, M. W., & Corey, J. L. (1994) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001251 · Cited by 139
Attention-Deficit/Hyperactivity Disorder and Substance Use: Symptom Pattern and Drug Choice
Clure, C. L., Brady, K. T., Saladin, M. E., Johnson, D. E., Waid, R., & Rittenbury, M. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101871 · Cited by 135
Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys
Moore, R. J., Vinsant, S. L., Nader, M. A., Porrino, L. J., & Friedman, D. P. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199809)30:1<88::aid-syn11>3.0.co;2-l · Cited by 135
Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey.
Howell, L. L., & Byrd, L. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12217-9 · Cited by 134
Self-citationNovel Approaches to the Treatment of Cocaine Addiction
Sofuoglu, M., & Kosten, T. R. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00002 · Cited by 134
Regulation of monoamine transporters: Influence of psychostimulants and therapeutic antidepressants
Jayanthi, L. D., & Ramamoorthy, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070373 · Cited by 134
The Neurobiology of Dopamine Signaling
Greengard, P. (2001) · Bioscience Reports · doi:10.1023/a:1013205230142 · Cited by 133
Lee, B., Platt, D. M., Rowlett, J. K., Adewale, A. S., & Spealman, R. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078733 · Cited by 132
Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody.
Melikian, H. E., McDonald, J., Gu, H., Rudnick, G., Moore, K. R., & Blakely, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32714-x · Cited by 131
Cited by
Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at Pharmacotherapy
Ciccarone, D. (2011) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2010.11.004 · Cited by 200
A highly tunable dopaminergic oscillator generates ultradian rhythms of behavioral arousal
Blum, I. D., Zhu, L., Moquin, L., Kokoeva, M. V., Gratton, A., Giros, B., & Storch, K.-F. (2014) · eLife · doi:10.7554/elife.05105 · Cited by 168
Zhu, J., & Reith, M. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927877 · Cited by 140
dela Peña, I., Gevorkiana, R., & Shi, W.-X. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.07.044 · Cited by 116
Illicit dopamine transients: reconciling actions of abused drugs
Covey, D. P., Roitman, M. F., & Garris, P. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.002 · Cited by 90
Metadata
- Authors
- Howell, L. L., & Kimmel, H. L.
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 75
- Issue
- 1
- Pages
- 196-217
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2107617181
- Cited by
- 255
- References
- 353
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.